Study on the rule of traditional Chinese medicine in the treatment of hot flashes related to endocrine therapy of breast cancer
ZHANG Ying1 LIU Qing2 ZHOU Xin1 LYU Lingyan1 WAN Donggui2
1.Clinical Medical College, China-Japan Friendship Hospital, Beijing University of Chinese Medicine, Beijing 100029, China;
2.Internal Oncology Department of Integrated Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing 100029, China
Abstract：Objective To explore the rules of traditional Chinese medicine on hot flashes related to endocrine therapy of breast cancer. Methods Clinical researches about hot flashes related to endocrine therapy were collected by using CNKI, Wanfang and VIP from the time of the database established to July 2019, with the terms “traditional Chinese medicine, breast cancer, endocrine therapy, hot flashesl”. The medication frequency of efficacy, four qi, five flavors and meridian entry were analyzed. The association rules and cluster analysis were used to find the drug pairs and the new formulas. Results Sixty-two articles were included, involving 114 medicines. The most used ones were Radix Paeoniae Alba. The most frequently used were tonifying and heat-clearing medicines. The medicines those were sweet and cold were widely used and the meridians of traditional Chinese medicine were mainly liver and kidney. 10 drug pairs and 4 new formulas were found by date mining. Conclusion Nourishing liver and kidney, soothing liver and relieving depression, nourishing yin and clearing heat are the main methods in the treatment of hot flashes related to endocrine therapy of breast cancer.
张英1 刘青2 周馨1 吕灵艳1 万冬桂2. 中医对乳腺癌内分泌治疗相关潮热用药规律的探索[J]. 中国医药导报, 2020, 17(10): 138-141.
ZHANG Ying1 LIU Qing2 ZHOU Xin1 LYU Lingyan1 WAN Donggui2. Study on the rule of traditional Chinese medicine in the treatment of hot flashes related to endocrine therapy of breast cancer. 中国医药导报, 2020, 17(10): 138-141.
[1] Jia WJ，Jia HX，Feng HY，et al. HER2-enriched tumors have the highest risk of local recurrence in Chinese patients treated with breast conservation therapy [J]. Asian Pac J Cancer Prev，2014，15（1）：315-320.
[2] Francis PA，Regan MM，Fleming GF，et al. Adjuvant ovarian suppression in premenopausual breast cancer [J]. N Engl J Med，2015，372（5）：436-446.
[3] Pagani O，Regan MM，Walley BA，et al. Adjuvant exemestane with ovarian suppression in premonopausal breast cancer [J]. N Engl J Med，2014，371（2）：107-118.
[4] Weaver KE，Camacho F，Hwang W，et al. Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low income women [J]. Am J Clin Oncol，2013，36（2）：181-187. doi：10.1097/COC.0b013e3182436ecl.
[5] 赫捷，赵平，陈万青.2011中国肿瘤登记年报[M].北京：军事医学科学出版社，2012：501.
[6] 李京京.激素治疗围绝经期综合征的疗效探讨[J].当代医学，2012，18（36）：73-74.
[7] 胡婧伊，刘胜.他莫昔芬相关潮热机制和乳癌术后潮热治疗的研究进展[J].现代中西医结合杂志，2017，26（5）：559-562.
[8] 钟赣生.中药学[M].北京：中国中医药出版社，2017.
[9] 国家药典委员会.中国药典[M].一部.北京：中国医药科技出版社，2010.
[10] 窦鹏伟. 面向中医方药分析的数据挖掘方法及应用研究[D]. 南京：南京中医药大学，2017.
[11] 吴益萍.丹栀逍遥散加减改善乳腺癌三苯氧胺治疗不良反应56例[J].福建中医药，2012，43（2）：27-28.
[12] 杨慧芬，罗华，杨欧欧，等.二至丸合桂枝汤对绝经前Luminal型乳腺癌治疗后潮热患者生殖激素、改良Kupperman评分和ki67表达的影响[J].中国医药导报，2016，13（36）：175-178.
[13] 宫深谋.益肾调肝方治疗乳腺癌患者类更年期综合征的疗效观察[J].实用中西医结合临床，2017，17（12）：83-84.
[14] 陈红，曾恩泉.乳腺癌类围绝经期综合征辨治体会[J].中医临床研究，2016，8（11）：102-104.
[15] 赵磊.更年期综合征存在问题及对策[J].中华中医药杂志，2014，29（11）：3524-3527.
[16] 李俊玲，常江，舒瑾.益肾解郁宁神法治疗围绝经期潮热例[J].陕西中医，2015，36（1）：48-50.
[17] 赵元，郑红霞，徐颖，等.中药植物雌激素的研究进展[J].中国中药杂志，2017，42（18）：3474-3487.
[18] 陆奕宇，苏式兵.中药植物雌激素与乳腺癌的研究[J].中成药，2010，32（6）：1010-1014.
[19] 孙宇，白文佩.更年期潮热的外周血管运动和中枢机制[J].国际妇产科学杂志，2014，41（4）：466-468.
[20] 王晓玲.滋阴通络中药联合他莫昔芬治疗Luminal B型乳腺癌疗效及对5-HT、INH-B水平的影响[J].现代中西医结合杂志，2018，27（11）：1194-1197.
2020, Vol. 17 
京公网安备 11010502046598号